A randomized, double-blind, placebo-controlled trial of deprenyl and thiotic acid in HIV-associated cognitive impairment

Neurology. 1999 Jun 10;52(9):1920-1.
No abstract available

Publication types

  • Clinical Trial
  • Comment
  • Comparative Study
  • Letter
  • Randomized Controlled Trial

MeSH terms

  • Antioxidants / adverse effects
  • Antioxidants / therapeutic use*
  • Cognition Disorders / drug therapy*
  • Cognition Disorders / virology*
  • Double-Blind Method
  • Humans
  • Monoamine Oxidase Inhibitors / adverse effects
  • Monoamine Oxidase Inhibitors / therapeutic use*
  • Selegiline / adverse effects
  • Selegiline / therapeutic use*
  • Thioctic Acid / adverse effects
  • Thioctic Acid / therapeutic use*

Substances

  • Antioxidants
  • Monoamine Oxidase Inhibitors
  • Selegiline
  • Thioctic Acid